Aldesleukin Completed Phase 3 Trials for Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies / Childhood Acute Monoblastic Leukemia (M5a) / Refractory Anemia With Ringed Sideroblasts / Chronic Myelomonocytic Leukemia / Secondary Myelodysplastic Syndromes / Refractory Anemia / Refractory Anemia With Excess Blasts in Transformation / Childhood Acute Monocytic Leukemia (M5b) / Childhood Acute Myeloblastic Leukemia With Maturation (M2) / Childhood Acute Myelomonocytic Leukemia (M4) / Childhood Acute Myeloblastic Leukemia Without Maturation (M1) / Childhood Acute Megakaryocytic Leukemia (M7) / Childhood Acute Erythroleukemia (M6) / De Novo Myelodysplastic Syndromes / Refractory Anemia With Excess Blasts / Childhood Myelodysplastic Syndromes Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00002798Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome